TNS4
Tensin-4 is a protein that in humans is encoded by the TNS4 gene.[3][4][5]
References
- ↑ "Human PubMed Reference:".
- ↑ "Mouse PubMed Reference:".
- ↑ Lo SH, Lo TB (Aug 2002). "Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer". Cancer Res. 62 (15): 4217–21. PMID 12154022.
- ↑ Sasaki H, Moriyama S, Mizuno K, Yukiue H, Konishi A, Yano M, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y (Apr 2003). "Cten mRNA expression was correlated with tumor progression in lung cancers". Lung Cancer. 40 (2): 151–5. doi:10.1016/S0169-5002(03)00037-0. PMID 12711115.
- ↑ "Entrez Gene: TNS4 tensin 4".
Further reading
- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
- Dias Neto E, Correa RG, Verjovski-Almeida S, et al. (2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.". Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3491–6. doi:10.1073/pnas.97.7.3491. PMC 16267
. PMID 10737800.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Sasaki H, Yukiue H, Kobayashi Y, et al. (2004). "Cten mRNA expression is correlated with tumor progression in thymoma.". Tumour Biol. 24 (5): 271–4. doi:10.1159/000076141. PMID 15001839.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Wan D, Gong Y, Qin W, et al. (2004). "Large-scale cDNA transfection screening for genes related to cancer development and progression.". Proc. Natl. Acad. Sci. U.S.A. 101 (44): 15724–9. doi:10.1073/pnas.0404089101. PMC 524842. PMID 15498874.
- Benzinger A, Muster N, Koch HB, et al. (2005). "Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.". Mol. Cell Proteomics. 4 (6): 785–95. doi:10.1074/mcp.M500021-MCP200. PMID 15778465.
- Lo SS, Lo SH, Lo SH (2005). "Cleavage of cten by caspase-3 during apoptosis.". Oncogene. 24 (26): 4311–4. doi:10.1038/sj.onc.1208571. PMID 15806167.
- Liao YC, Si L, deVere White RW, Lo SH (2007). "The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.". J. Cell Biol. 176 (1): 43–9. doi:10.1083/jcb.200608015. PMC 2063623. PMID 17190795.
- Katz M, Amit I, Citri A, et al. (2007). "A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.". Nat. Cell Biol. 9 (8): 961–9. doi:10.1038/ncb1622. PMID 17643115.
- Mouneimne G, Brugge JS (2007). "Tensins: a new switch in cell migration.". Dev. Cell. 13 (3): 317–9. doi:10.1016/j.devcel.2007.08.010. PMID 17765673.
